BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  AmerisourceBergen Reports Fiscal 2017 Fourth Quarter and Year End Results

  AmerisourceBergen reported that in its fiscal year 2017 fourth quarter ended September 30, 2017, revenue increased 4.2 percent to $39.1 billion.

  November 2, 2017

   · 

  45 min read
• Business

  Compugen to Enter Research Collaboration With Mount Sinai on Novel Myeloid Immuno-Oncology Targets

  Multi-year collaboration led by Dr. Miriam Merad.

  November 2, 2017

   · 

  6 min read
• 

  Policy

  Ortho Dermatologics Announces FDA Filing Acceptance for IDP-118, Novel Plaque Psoriasis Treatment

  If approved, IDP-118 will be the first and only topical lotion that contains a unique combination of halobetasol propionate and tazarotene in one formulation to treat plaque psoriasis in adult patients.

  November 2, 2017

   · 

  2 min read
• Drug Development

  BioLineRx Announces Oral Presentation at ASH of Data Supporting BL-8040 as Robust Mobilizer of Hematopoietic Stem Cells (HSC) associated With Long-Term Engraftment

  The study further showed that BL-8040-mobilized HSCs can successfully engraft the bone marrow and spleen of immunodeficient mice.

  November 2, 2017

   · 

  6 min read
• Pharm Country

  Bristol-Myers Squibb Presents Researching Personalized Medicine for the Potential Treatment of Autoimmune Diseases at 2017 American College of Rheumatology and Association of Rheumatology Health Professionals Annual Meeting

  Bristol-Myers Squibb today confirmed that 34 abstracts related to ORENCIA (abatacept) and the Company’s immunoscience pipeline

  November 2, 2017

   · 

  23 min read
• Business

  LivaNova Reports Third Quarter 2017 Results

  For the third quarter of 2017, worldwide sales were $309.7 million, an increase of 4.9 percent on a reported basis and an increase of 3.1 percent on a constant currency basis, as compared to the same quarter of the previous year.

  November 2, 2017

   · 

  23 min read
• Business

  Rigel Welcomes Gregg Lapointe to Board of Directors

  Currently the CEO and co-founder of Cerium Pharma, Mr. Lapointe offers Rigel’s board nearly three decades of commercial and financial experience bringing products to market in the areas of medical devices and rare diseases.

  November 2, 2017

   · 

  4 min read
• Business

  Teva Reports Third Quarter 2017 Financial Results

  Revenues in the third quarter of 2017 were $5.6 billion, up 1% compared to the third quarter of 2016.

  November 2, 2017

   · 

  41 min read
• Business

  BD Announces Results For 2017 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2018 Guidance

  On a comparable, currency-neutral basis, fourth quarter revenues grew 4.4 percent, which includes an estimated 100 basis point adverse impact from the previously disclosed change in the U.S. dispensing business model.

  November 2, 2017

   · 

  79 min read
• Innovate UK Awards Grant to MiNA Therapeutics and LGC LINK

  The grant of up to approximately £400,000, with additional funding from MiNA and LGC LINK, will support a two-year research project.

  November 2, 2017

   · 

  3 min read